Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis. [PDF]
Raventós A +9 more
europepmc +1 more source
Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS. [PDF]
Miesbach W +11 more
europepmc +1 more source
Effect of factor VIII and FVIII/PC ratio on portal vein thrombosis in liver cirrhosis: a systematic review and meta‑analysis. [PDF]
Wu Z +5 more
europepmc +1 more source
Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without Inhibitors. [PDF]
Klamroth R +9 more
europepmc +1 more source
Corrigendum to "Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS". [PDF]
europepmc +1 more source
Related searches:
Studies on the Characterization of Factor VIII and a Co-factor VIII
Thrombosis and Haemostasis, 1974SummaryFactor VIII occurs in the body in two different forms. In lymph factor VIII is bound to chylomicra. In plasma, factor VIII is bound to a protein.After delipidation of chylomicra we obtained a glycoprotein with a high polysaccharide content and a molecular weight of approx.
H. L. M. A Vandenbussche-Scheffers +4 more
openaire +3 more sources

